TOVX

Theriva Biologics, Inc.

0.19

USD

TOVX Earnings Reports

Positive Surprise Ratio

TOVX beat 33 of 39 last estimates.

85%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.44

Implied change from Q3 25 (Revenue/ EPS)

-2.22%

Implied change from Q4 24 (Revenue/ EPS)

-86.63%

Theriva Biologics, Inc. earnings per share and revenue

On Nov 12, 2025, TOVX reported earnings of -0.45 USD per share (EPS) for Q3 25, beating the estimate of -0.77 USD, resulting in a 41.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.05% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an decrease of -2.22% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Theriva Biologics, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Theriva Biologics, Inc. reported EPS of -$0.45, beating estimates by 41.57%, and revenue of $0.00, 0% as expectations.

How did the market react to Theriva Biologics, Inc.'s Q3 2025 earnings?

The stock price moved up 8.05%, changed from $0.28 before the earnings release to $0.30 the day after.

When is Theriva Biologics, Inc. expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Theriva Biologics, Inc.'s next earnings report?

Based on 4 analysts, Theriva Biologics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.